Open an account

West Pharmaceutical Services

WST · NYSE

$388.78+$4.87 (+1.27%)TodayMarket closed ·
Prev close $383.91

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Employees
10,800
Headquarters
Exton, Pennsylvania
Listed
Jul 27, 1923
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
westpharma.com

WST key statistics

Market cap
23.90B
Price-earnings ratio
49.16
Dividend yield
0.22%
Average volume
521.57K
Volume
344.55K
Open price
$387.54
High today
$389.75
Low today
$384.21
52 Week high
$386.26
52 Week low
$223.83

West Pharmaceutical Services (WST) at a glance

As of Oct 20, 2026, West Pharmaceutical Services (WST) shares are priced at $388.78, giving the company a market cap of 23.90B, a price-to-earnings ratio of 49.16 and a dividend yield of 0.22%.

Today the stock has traded between $384.21 and $389.75. The current price is 1.2% above the day's low and 0.2% below its high.

Volume so far is 344.55K shares, below the average of 521.57K shares a day.

Over the past year West Pharmaceutical Services has ranged from $223.83 to $386.26, and now sits 102% of the way up that range.

West Pharmaceutical Services met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $2.37 per share against an estimate of $2.10.

The average analyst price target is $411.63, 5.9% above the current price, from 11 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 11 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 19 analystsAvg $411.63
Low
$340.37
Now
$388.78
High
$481.95

WST earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 16.0% on average.

  1. Q3 FY24: reported $1.85 per share against an estimate of $1.51
  2. Q4 FY24: reported $1.82 per share against an estimate of $1.74
  3. Q1 FY25: reported $1.45 per share against an estimate of $1.25
  4. Q2 FY25: reported $1.84 per share against an estimate of $1.52
  5. Q3 FY25: reported $1.96 per share against an estimate of $1.70
  6. Q4 FY25: reported $2.04 per share against an estimate of $1.85
  7. Q1 FY26: reported $2.13 per share against an estimate of $1.69
  8. Q2 FY26: reported $2.37 per share against an estimate of $2.10

WST news

  • Press releasePRNewswire

    West Declares Quarterly Dividend

  • Piero Cingari

    This 146-Old Can Maker Is On a Winning Streak Unseen In Its Half-Century Stock History

  • Press releasePRNewswire

    West to Host Third-Quarter 2026 Conference Call

  • Press releasePRNewswire

    West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide

  • Press releasePRNewswire

    West to Participate in Upcoming Investor Conferences

  • Vandana Singh

    West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum

  • Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call

  • Press releasePRNewswire

    West Declares Quarterly Dividend

Similar companies

Companies in the same industry as West Pharmaceutical Services

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.